rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
14
|
pubmed:dateCreated |
2010-8-30
|
pubmed:abstractText |
Interleukin-6 (IL-6) is a multifunctional cytokine that has been implicated in the modulation of growth and progression of prostate cancer. Decreased expression of the tyrosine phosphatase SHP-1, involved in regulation of cytokine and tyrosine kinase receptor signaling, has been shown to be associated with less favorable outcome among prostate cancer patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1097-0045
|
pubmed:author |
|
pubmed:copyrightInfo |
(c) 2010 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1491-500
|
pubmed:meshHeading |
pubmed-meshheading:20687222-Caspase 3,
pubmed-meshheading:20687222-Caspase 7,
pubmed-meshheading:20687222-Cell Division,
pubmed-meshheading:20687222-Cell Line, Tumor,
pubmed-meshheading:20687222-DNA Primers,
pubmed-meshheading:20687222-Disease Progression,
pubmed-meshheading:20687222-Down-Regulation,
pubmed-meshheading:20687222-Extracellular Signal-Regulated MAP Kinases,
pubmed-meshheading:20687222-Humans,
pubmed-meshheading:20687222-Immunohistochemistry,
pubmed-meshheading:20687222-Interleukin-6,
pubmed-meshheading:20687222-Kinetics,
pubmed-meshheading:20687222-Lymphatic Metastasis,
pubmed-meshheading:20687222-Male,
pubmed-meshheading:20687222-PTEN Phosphohydrolase,
pubmed-meshheading:20687222-Prostatic Neoplasms,
pubmed-meshheading:20687222-Protein Tyrosine Phosphatase, Non-Receptor Type 6,
pubmed-meshheading:20687222-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:20687222-STAT3 Transcription Factor,
pubmed-meshheading:20687222-Up-Regulation
|
pubmed:year |
2010
|
pubmed:articleTitle |
Role of the protein tyrosine phosphatase SHP-1 in Interleukin-6 regulation of prostate cancer cells.
|
pubmed:affiliation |
Department of Laboratory Medicin, Tumour Biology, Lund University, Malmö University Hospital, Malmö, Sweden. helena.tassidis@med.lu.se
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|